Related Experiment Video
Updated: Jul 31, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Hepatitis C virus infection in pediatric patients
1Division of Gastroenterology and Hepatology, Department of Pediatrics and Section of Hepatobiliary Diseases, University of Florida College of Medicine, Gainesville, Florida 32610-0296, USA.
Insights
Hepatitis C virus (HCV) infection in children is not well understood. While often mild, it can cause serious liver issues, but some treatments show effectiveness.
Area of Science:
- Hepatology
- Pediatric Infectious Diseases
- Virology
Background:
- Limited knowledge exists regarding hepatitis C virus (HCV) infection in pediatric populations compared to adults.
- Pediatric HCV infection can stem from blood transfusions, organ transplants, or maternal transmission, with some cases lacking clear risk factors.
- HCV in children is often identified in those with previously undiagnosed liver conditions.
Purpose of the Study:
- To review the current understanding of hepatitis C virus infection in children.
- To highlight the evolution, risk factors, and clinical outcomes of HCV in pediatric patients.
- To discuss treatment strategies for pediatric HCV infection.
Main Methods:
- Literature review of pediatric HCV infection.
- Analysis of risk factors, clinical presentation, and disease progression in children.
- Evaluation of treatment efficacy, including interferon therapy.
Main Results:
- HCV infection in children typically results in mild chronic liver disease, but can progress to chronic active hepatitis and cirrhosis.
- Interferon therapy has demonstrated effectiveness in a subset of pediatric patients with chronic hepatitis C.
- Identified risk factors include transfusion history, organ transplantation, and mother-to-child transmission.
Conclusions:
- Further research is needed to fully elucidate HCV infection dynamics in children.
- Early detection and appropriate management are crucial for improving outcomes in pediatric HCV patients.
- Treatment options, such as interferon, offer potential benefits for managing chronic hepatitis C in children.
Abstract:
In contrast to our understanding of hepatitis C virus infection in adults, relatively little is known about the evolution and treatment of HCV infection in pediatric patients. Children at risk for HCV infection include recipients of multiple blood-product transfusions, organ transplantation and infants born to HCV-infected mothers. A proportion of HCV-infected pediatric patients do not have an identifiable risk factor. HCV infection is commonly detected in children previously presumed to have non-A, non-B hepatitis and cryptogenic liver disease. HCV infection usually leads to mild chronic liver disease in children but is also associated with chronic active hepatitis and cirrhosis. Interferon therapy is effective in a proportion of patients with chronic hepatitis C.
More Related Videos
10:25"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Published on: February 19, 2019
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Poliomyelitis
Cytomegalovirus Disease
Hepatitis
Viral Hepatitis I: Introduction